BindingDB logo
myBDB logout

19 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
22380777 16 Synthesis and HIV-1 RT inhibitory action of novel (4/6-substituted benzo[d]thiazol -2-yl)thiazolidin-4-ones. Divergence from the non-competitive inhibition mechanism.BDB Aristotle University of Thessaloniki
22233539 90 Nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors: synthesis, structure-activity relationship analysis, and biological activity.BDB Shandong University
24719329 3 Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation.BDB McGill University
28371664 15 Synthesis and study of anti-HIV-1 RT activity of 5-benzoyl-4-methyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-2-one derivatives.BDB Birla Institute of Technology & Science
28160944 6 Dihydropyrimidinone-isatin hybrids as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.BDB Jaipur National University
27992102 6 Natural Product Kuwanon-L Inhibits HIV-1 Replication through Multiple Target Binding.BDB University of Siena
27288643 16 Rational design, synthesis, anti-HIV-1 RT and antimicrobial activity of novel 3-(6-methoxy-3,4-dihydroquinolin-1(2H)-yl)-1-(piperazin-1-yl)propan-1-one derivatives.BDB Birla Institute of Technology & Science
19902958 24 Solid phase synthesis of novel pyrrolidinedione analogs as potent HIV-1 integrase inhibitors.BDB Bristol-Myers Squibb
18763751 25 Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.BDB Merck Research Laboratories
17154493 13 4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.BDB IRBM-MRL
18217703 51 Design and synthesis of bicyclic pyrimidinones as potent and orally bioavailable HIV-1 integrase inhibitors.BDB IRBM-MRL
17824681 55 Discovery and synthesis of HIV integrase inhibitors: development of potent and orally bioavailable N-methyl pyrimidones.BDB IRBM-MRL